Attached files
| file | filename |
|---|---|
| EX-32.2 - CERTIFICATION PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 - DOW INC. | dowinc-q2x6302021ex322.htm |
| EX-32.1 - CERTIFICATION PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 - DOW INC. | dowinc-q2x6302021ex321.htm |
| EX-31.2 - CERTIFICATION PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002 - DOW INC. | dowinc-q2x6302021ex312.htm |
| EX-31.1 - CERTIFICATION PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002 - DOW INC. | dowinc-q2x6302021ex311.htm |
| 10-Q - 10-Q - DOW INC. | dow-20210630.htm |
| Ankura Consulting Group, LLC's Consent | EXHIBIT 23 | |||||||
Ankura Consulting Group, LLC (“Ankura”) hereby consents to the use of Ankura's name and the reference to Ankura's reports in this Quarterly Report on Form 10-Q of Dow Inc. and The Dow Chemical Company for the period ended June 30, 2021, and the incorporation by reference thereof in the following Registration Statements of Dow Inc. and The Dow Chemical Company:
DOW INC.
| Form S-3: | |||||
| Nos. | 333-230668 | ||||
| 333-232862 | |||||
| Form S-8: | |||||
| Nos. | 333-220352-01 | ||||
| 333-230680 | |||||
| 333-230681 | |||||
| 333-255472 | |||||
| 333-255473 | |||||
THE DOW CHEMICAL COMPANY
| Form S-3: | |||||
| No. | 333-232862-01 | ||||
| Form S-4: | |||||
| Nos. | 333-88443 | ||||
| 333-234108 | |||||
| Form S-8: | |||||
| Nos. | 33-61795 | ||||
| 333-40271 | |||||
| 333-91027 | |||||
| 333-103519 | |||||
| 333-220352 | |||||
Date: July 23, 2021
| /s/ AMY BROCKMAN | ||
| Amy Brockman Senior Managing Director Ankura Consulting Group, LLC | ||
67